3 companies
D'Ieteren Group
Market Cap: €9.0b
Operates as an investment company in Belgium, France, rest of Europe, and internationally.
DIE
€170.20
7D
3.6%
1Y
-6.5%
argenx
Market Cap: €44.1b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€709.20
7D
2.7%
1Y
39.4%
UCB
Market Cap: €46.5b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€244.10
7D
2.3%
1Y
57.7%